tiprankstipranks
Bristol-Myers Squibb (MX:BMY)
:BMY
Mexico Market

Bristol-Myers Squibb (BMY) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
17Bullish
5Neutral
0Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Bristol-Myers Squibb’s (BMY) Moving Averages Convergence Divergence (MACD) indicator is 13.91, suggesting Bristol-Myers Squibb is a Buy.
Bristol-Myers Squibb’s (BMY) 20-Day exponential moving average is 1115.56, while Bristol-Myers Squibb’s (BMY) share price is $1,120.18, making it a Buy.
Bristol-Myers Squibb’s (BMY) 50-Day exponential moving average is 1082.28, while Bristol-Myers Squibb’s (BMY) share price is $1,120.18, making it a Buy.

Bristol-Myers Squibb (BMY) Pivot Points

Sep 08, 2026, 09:05 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1,032.66
1,075.23
1,102.62
1,145.19
1,172.58
1,215.15
1,242.54
Fibonacci
1,075.23
1,101.96
1,118.47
1,145.19
1,171.92
1,188.43
1,215.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bristol-Myers Squibb (BMY) Moving Averages

Sep 08, 2026, 09:05 AM
Period
Simple
Exponential
MA5
1,128.04Buy
1,127.99Buy
MA10
1,124.07Buy
1,124.30Buy
MA20
1,114.08Buy
1,115.56Buy
MA50
1,075.53Buy
1,082.28Buy
MA100
1,027.22Buy
1,045.07Buy
MA200
1,001.03Buy
991.65Buy
Bristol-Myers Squibb’s (BMY) 10-Day exponential moving average is 1124.30, while Bristol-Myers Squibb’s (BMY) share price is $1,120.18, making it a Buy.
Bristol-Myers Squibb’s (BMY) 100-Day exponential moving average is 1045.07, while Bristol-Myers Squibb’s (BMY) share price is $1,120.18, making it a Buy.
Bristol-Myers Squibb’s (BMY) stock price is $1,120.18 and Bristol-Myers Squibb’s (BMY) 50-day simple moving average is 1075.53, creating a Buy signal.
Bristol-Myers Squibb’s (BMY) stock price is $1,120.18 and Bristol-Myers Squibb’s (BMY) 100-day simple moving average is 1027.22, creating a Buy signal.
Bristol-Myers Squibb’s (BMY) stock price is $1,120.18 and Bristol-Myers Squibb’s (BMY) 200-day simple moving average is 1001.03, creating a Buy signal.

Bristol-Myers Squibb (BMY) Technical Indicators

Sep 08, 2026, 09:05 AM
Name
Value
Implied Action
RSI (14)
67.84
Neutral
STOCH (9,6)
37.12
Neutral
STOCHRSI (14)
37.12
Neutral
MACD (12,26)
13.91
Buy
ADX (14)
19.40
Buy
Williams %R
-62.88
Buy
CCI (14)
71.97
Neutral
ATR (14)
98.21
-
Ultimate Oscillator
57.20
Neutral
ROC
4.12
Buy
Bristol-Myers Squibb’s (BMY) Relative Strength Index (RSI) is 67.84, creating a Neutral signal.
Bristol-Myers Squibb’s (BMY) Trend Strength Indicator (ADX) is 19.40, creating a Buy signal.
Bristol-Myers Squibb’s (BMY) Commodity Channel Index (CCI) is 71.97, creating a Neutral signal.
Bristol-Myers Squibb’s (BMY) Price Rate of Change (ROC) is 4.12, creating a Buy signal.

FAQ

Is BMY a Buy, Hold, or Sell?
Based on BMY’s technical indicators, BMY is a Strong Buy.
    What is BMY’s RSI (14)?
    BMY’s RSI (14) is 67.84, which suggests BMY is a Neutral.
      What is BMY’s MACD?
      BMY’s MACD is 13.91, which suggests BMY is a Buy.
        What is BMY’s 5-day moving average?
        BMY’s 5-day moving average is 1128.04, which suggests BMY is a Buy.
          What is BMY’s 20-day moving average?
          BMY 20-day moving average is 1114.08, which suggests BMY is a Buy.
            What is BMY’s 50-day moving average?
            BMY’s 50-day moving average is 1075.53, which suggests BMY is a Buy.
              What is BMY’s 200-day moving average?
              BMY’s 200-day moving average is 1001.03, which suggests BMY is a Buy.
                What is BMY’s Williams % R (14)?
                BMY’s Williams % R (14) is -62.88, which suggests BMY is a Buy.
                  What is BMY’s CCI (14)?
                  BMY’s CCI (14) is 71.97, which suggests BMY is a Neutral.
                    What is the share price of Bristol-Myers Squibb?